HOney versus Nasal Eradication of staphYlococci for the Prevention Of Tenckoff infections in PD
Principal Investigator: Professor David Johnson
Clinical Research Associate: Liza Vergara (AKTN)
Trial Number: AKTN 06.02
Population: Peritoneal Dialysis patients
Final recruitment number: 371 (target of 370)
Intervention: Medihoney applied to exit site twice daily versus standard practice for 24 months
primary outcome: Time to event: exit-site infection, tunnel infection, peritonitis
Results: The HONEYPOT trial showed that topical honey is not more effective than standard practice in the prevention of catheter-associated infections in peritoneal dialysis patients. Results of the study have been published in the Lancet Infectious Diseases and peritoneal Dialysis International.
Publications
Read the full publications via the links below:
Click here to read the Main Results paper
Click here to read the Methods paper
Click here to read the Microbiology sub-study
Click here to read the SAP paper
Click here to read Representativeness ANZData